Skip to main content

Bios Life

Bios Life is an AI-powered cancer surveillance platform that combines genomic, clinical, and lifestyle data to deliver personalized screening and survivorship care. The company uses a digital twin model of each patient's biology to enable continuous, proactive risk monitoring. Its clinician-led virtual clinic provides integrated care programs tailored to individual risk profiles.

  • Artificial Intelligence
  • Digital Health
  • Healthcare Technology
  • Software Only
Addison, United States · HQ
191K+ followers
Updated 10 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Nearly 40% of people will get cancer in their lifetime, and more than 1 in 3 will be diagnosed at stage 3 or 4. Despite diagnostic innovation, surveillance for high-risk individuals and cancer survivors remains generic, fragmented, and reactive, relying on population averages rather than individual risk and waiting for problems to appear instead of proactively managing them.

Solution

Bios Life delivers personalized, integrated, and continuous cancer surveillance powered by AI and grounded in human care. The platform reads genomic, clinical, and lifestyle data together through novel algorithms trained on millions of data points from real patients, creating a dynamic digital twin of each individual's biology that updates over time. This pan-cancer risk intelligence enables a clinician-led virtual clinic team to provide personalized screening programs and holistic survivorship care, connecting patients to specialized expertise beyond primary care. Care is delivered through a mobile application, putting personalized care in the palm of the patient's hand.

Target Audience

Primary customers are high-risk individuals seeking proactive cancer screening and cancer survivors requiring ongoing surveillance and holistic care, as well as healthcare systems and diagnostics companies that refer patients to the platform.

Features

  • Novel AI algorithms trained on multimodal datasets including genome, history, labs, and daily signals for pan-cancer risk intelligence
  • Digital twin technology that creates a dynamic model of the patient's biology, updating over time as new data becomes available
  • Personalized screening programs based on individual risk profiles rather than population averages
  • Dedicated survivorship program addressing the unique needs of cancer survivors through continuous surveillance
  • Virtual clinic staffed by specialized clinical teams who know each patient's history, accessible on demand
  • Mobile application for personalized care delivery and patient engagement
This profile is AI-generated and may contain inaccuracies.